May 07, 2019
Starpharma to present at US Drug Delivery Conference
Melbourne, Australia; 7 May 2019: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that it will be presenting its DEP® platform at the 2nd Annual Drug Delivery West conference in San Francisco on 6-7 May 2019 (US time).
The Drug Delivery West conference is attended by senior licensing and development executives from large pharmaceutical and specialist drug delivery companies. Speakers include industry experts from companies such as Genentech, Allergan, GSK, Biogen, Amgen, Novartis, Eli Lilly and Bayer as well as representatives from leading drug delivery companies.
Starpharma’s VP Business Development, Dr Tony Eglezos, will be presenting an overview of the benefits of the DEP® platform and its potential use in combination with immuno-oncology agents, as well as its application for radiopharmaceuticals and antibody-drug conjugates (ADCs). A copy of the presentation is attached and will be available on Starpharma’s website at www.starpharma.com.
Starpharma will also be conducting partnering discussions with pharmaceutical companies at the conference.
Download ASX Announcement: Starpharma to present at US Drug Delivery Conference (pdf file, 1,712kb)